In ₹ Crore except Per Share 12 Months Ending | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|
| Total Income | 2,349.3 | 4,272.5 | 1,267.5 | 4,347.0 | |
| Expenses | |||||
| Total Expenses | 2,237.0 | 4,172.7 | 1,364.5 | 4,279.2 | |
| Revenue Detail — as filed | |||||
| + Investment Income | 28.1 | 30.8 | 29.3 | 34.6 | |
| + Income from Investments (net) | 60.1 | 1,304.3 | -1,715.9 | 2,268.8 | |
| Expense Detail — as filed | |||||
| + Employee Remuneration & Welfare | 174.8 | 179.4 | 234.3 | 215.0 | |
| + Commission | 148.5 | 182.7 | 196.1 | 117.2 | |
| + Commission (net) | 148.5 | 182.7 | 196.1 | 117.2 | |
| + Provision — Doubtful Debts incl. Write-off | 0.0 | 0.7 | -0.2 | 0.5 | |
| Profit Build-up — Alternate / Pre-Ind-AS Tags | |||||
| Profit / (Loss) before Tax | 45.3 | 30.8 | 38.6 | 31.5 | |
| + Current Taxes | 4.5 | 3.2 | 3.9 | 3.4 | |
| + Provisions for Taxes | 4.5 | 3.2 | 3.9 | 3.4 | |
| PAT before Extraordinary Items | 40.8 | 27.7 | 34.7 | 28.1 | |
| PAT after Extraordinary Items | 40.8 | 27.7 | 34.7 | 28.1 | |
| Profit Carried to Balance Sheet | 468.1 | 495.7 | 530.5 | 558.6 | |
| Per Share — as-filed variants | |||||
| Basic & Diluted EPS before Extraordinary (not annualised) | 0.43 | 0.29 | 0.37 | 0.30 | |
| Basic & Diluted EPS after Extraordinary (not annualised) | 0.43 | 0.29 | 0.37 | 0.30 | |
| Appropriations & Transfers | |||||
| Reserves & Surplus excl. Revaluation Reserve | 593.1 | 620.7 | 655.5 | 683.6 | |
| + Final Dividend | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — Revenue Account (Policyholders') | |||||
| + Gross Premium Income | 2,294.9 | 2,889.3 | 3,114.2 | 2,161.1 | |
| + Net Premium Income | 2,259.7 | 2,867.2 | 3,060.7 | 2,047.5 | |
| + First-year Premium | 575.1 | 938.0 | 673.9 | 466.1 | |
| + Renewal Premium | 1,419.8 | 1,668.4 | 2,126.8 | 1,117.4 | |
| + Single Premium | 300.0 | 282.9 | 313.6 | 577.6 | |
| + Commission — First-year Premium | 86.4 | 127.0 | 122.6 | 75.3 | |
| + Commission — Renewal Premium | 42.9 | 34.8 | 51.2 | 24.1 | |
| + Commission — Single Premium | 19.1 | 20.9 | 22.4 | 17.8 | |
| + Expenses of Management | 427.0 | 527.4 | 580.3 | 447.2 | |
| + Operating Expenses — Insurance Business | 278.5 | 344.7 | 384.2 | 330.0 | |
| + Expenses — Non-insurance | 1.7 | 2.8 | 3.7 | 7.2 | |
| + Benefits Paid (net) | 1,260.5 | 987.6 | 1,256.0 | 834.7 | |
| + Change in Actuarial Liability | 530.2 | 2,657.6 | -471.7 | 2,997.3 | |
| + Bonus Allocated to Policyholders | 0.0 | 0.0 | 118.3 | 0.0 | |
| + Interim Bonus Paid | 8.6 | 6.4 | 7.5 | 5.1 | |
| + GST on Linked Charges | 19.4 | 0.0 | -0.2 | 0.0 | |
| Surplus in the Revenue Account | 112.3 | 99.9 | -96.9 | 67.8 | |
| Net Surplus / (Deficit) | 112.3 | 99.9 | -96.9 | 67.8 | |
| + Funds for Future Appropriation | 69.1 | 1.1 | -26.1 | 40.5 | |
| + Policyholders' Liabilities to Shareholders' Fund | 27.9 | 29.1 | 28.0 | 29.5 | |
| Insurance — Shareholders' Account | |||||
| + Income under Shareholders' Account | 28.1 | 30.8 | 29.3 | 35.9 | |
| + Shareholders' Account Income | 71.3 | 129.5 | -41.5 | 63.2 | |
| + Shareholders' Account Expenses | 26.0 | 98.7 | -80.1 | 31.7 | |
| + Transfer from Policyholders' Account | 43.2 | 98.7 | -70.8 | 27.3 | |
| + Transfer of Funds to Policyholders' Account | 24.4 | 95.2 | -83.6 | 24.1 | |
| + Transferred to Shareholders' Account | 43.2 | 98.7 | -70.8 | 27.3 | |
| Shareholders' Fund — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | |
| Shareholders' Fund — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — Fund NPAs | |||||
| + Gross NPAs — Shareholders' Fund | 86.1 | 86.1 | 86.1 | 86.1 | |
| + Gross NPAs — Linked Non-participating | 32.4 | 32.4 | 32.4 | 32.4 | |
| + Gross NPA % — Linked Non-participating | 0.00 | 0.00 | 0.00 | 0.00 | |
| + Linked Non-participating — with Unrealised Gains | -0.0 | 0.0 | -0.0 | 0.0 | |
| + Linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Participating — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — with Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Non-linked Non-participating — without Unrealised Gains | 0.0 | 0.0 | 0.0 | 0.0 | |
| Insurance — IRDAI Ratios (as filed, not percentages) | |||||
| Solvency Ratio | 1.98 | 1.91 | 1.90 | 1.98 | |
| Conservation Ratio | 0.86 | 0.88 | 0.85 | 0.85 | |
| Expenses of Management Ratio | 0.19 | 0.18 | 0.19 | 0.21 | |
| Persistency — 13th Month | 0.82 | 0.85 | 0.82 | 0.82 | |
| Persistency — 25th Month | 0.71 | 0.67 | 0.70 | 0.72 | |
| Persistency — 37th Month | 0.63 | 0.63 | 0.63 | 0.70 | |
| Persistency — 49th Month | 0.61 | 0.61 | 0.59 | 0.61 | |
| Persistency — 61st Month | 0.59 | 0.57 | 0.51 | 0.53 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||
| Related-party Transactions — During the Period | 1,057.1 | — | 922.3 | — | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||
| Other Operating Expenses | 103.7 | 165.3 | 149.9 | 115.0 | |